JAVITT JONATHAN C (Chief Executive Officer) purchased 89.6% of their position (40K shares) of NRX PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $46.8K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/18/2024ACC: 0001415889-24-029694
DirectorOfficer10% Owner· Chief Executive Officer
Since May 2021
+40K
Net shares
Net buyer
$46.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
40K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+40K
Price / share
$1.17
Trade value
$46.80K
% of position
89.6%
12/17/2024
44.63K→84.63K
Total
Net shares
+40K
Net value
$46.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/17/2024 | P · Purchase | +40K | $1.17 | $46.80K | 89.6% | 44.63K | 84.63K |
| Total | +40K | $46.80K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned30K
Common Stock
IndirectShares owned142.20K
Common Stock
IndirectShares owned1.26M
Total
1.43M indirect1.43M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 30K | Indirect |
| Common Stock | 142.20K | Indirect |
| Common Stock | 1.26M | Indirect |
| Total | 1.43M | 1.43M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported